Reporting on circulating tumor DNA monitoring in metastatic cancer: From clinical validity to clinical utility

Caroline Brenner Thomsen*, Amanda Dandanell Juul, Anna Cecilie Lefèvre, Christina Glismand Truelsen, Edina Dizdarevic, Heidi Ryssel, Ina Mathilde Kjær, Karen Lycke Wind, Louise Bach Callesen, Louise Faaborg Larsen, Malene Støchkel Frank, Rikke Fredslund Andersen, Karen Lise Garm Spindler, Anders Jakobsen

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

1 Downloads (Pure)
Original languageEnglish
JournalCancer
Volume128
Issue number11
Pages (from-to)2052-2057
ISSN0008-543X
DOIs
Publication statusPublished - Jun 2022

Keywords

  • circulating tumor DNA (ctDNA)
  • clinical utility
  • metastatic cancer
  • monitoring
  • reporting on circulating tumor DNA
  • standardization

Cite this